[1]
A. Haykır Solay, “Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity”, Turkish Journal of Gastroenterology, vol. 29, no. 5, pp. 561–565, Jan. 2018.